Benzinga’s Top Ratings Upgrades, Downgrades For January 17, 2023
Upgrades For Casa Systems Inc (NASDAQ:CASA), Northland Capital Markets upgraded the previous rating of Market Perform to Outperform.…
HC Wainwright & Co. Downgrades Oramed Pharmaceuticals to Neutral
HC Wainwright & Co. analyst Raghuram Selvaraju downgrades Oramed Pharmaceuticals (NASDAQ:ORMP) from Buy to Neutral.
Gold Tops $1,900 After US CPI Report, S&P 500 Rises 0.5%
U.S. stocks traded higher toward the end of trading, following the release of inflation data.
12 Health Care Stocks Moving In Thursday’s Intraday Session
Gainers Yield10 Bioscience (NASDAQ:YTEN) shares increased by 35.2% to $2.84 during Thursday’s regular session. Trading volume for Yield10…
US Stocks Turn Higher; Dow Jumps 200 Points
U.S. stocks turned higher midway through trading, following the release of inflation data.
Why Akerna Shares Are Trading Higher By 97%; Here Are 20 Stocks Moving Premarket
Gainers
Akerna Corp. (NASDAQ: KERN) rose 97.4% to $1.91 in pre-market trading after the company reported the sale of 365 Cannabis for $2.8 million.
Reported Late Wednesday, Oramed Pharmaceuticals Announces Top-line Results From Phase 3 Trial Of ORMD-0801 For The Treatment Of Type 2 Diabetes
Oramed Pharmaceuticals Inc. (Nasdaq/TASE: ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, announced today top-line results from its Phase 3 randomized,
Jim Cramer Says Avoid This Stock: ‘Too Expensive’
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Blackline, Inc. (NASDAQ: BL) was an enterprise software company that was losing money.